·7 min read
Ruslan Averin: CVS Health reports Q3 on 4 November; analysts see EPS of $1.62 and Aetna's cost ratio at 92.4%
CVS Health Q3 2026 earnings preview: Zacks sees EPS of $1.62 and revenue of $105.04B; Aetna's 92.4% MBR and the $7.90–8.10 guide decide CVS stock.